A examine of analyst suggestions on the main brokerages exhibits that Johnson & Johnson (Image: JNJ) is the #Eight dealer choose, on common, out of the 30 shares making up the Dow Jones Industrial Common, in line with ETF Channel. Johnson & Johnson additionally is available in above the median of analyst picks among the many broader S&P 500 index elements, claiming the #122 spot out of 500.
Beneath is a chart of rank over time:
JNJ operates within the Medicine & Prescription drugs sector, amongst firms like Pfizer Inc (PFE) which is down about 2.8% right now, and Novartis (NVS) buying and selling decrease by about 1.3%. Beneath is a 3 month value historical past chart evaluating the inventory efficiency of JNJ, versus PFE and NVS.
JNJ is at present buying and selling off about 0.8% noon Tuesday.
15 Forgotten Giants of the S&P 500: Analysts’ Present Least Favorites »
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.
www.nasdaq.com